PROVIDER PROFILE · NPI 1811077225

Charles OsborneMD

Internal MedicineHouston, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

156

Unique beneficiaries

—

Total services

286

Distinct HCPCS

Medicare payment

$23K

Peer benchmark

Total Medicare services vs. 6,183 Internal Medicine providers in TX — below median (cohort median 673).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$186K

Distinct drugs

Brand share

17.6%

Top prescribed drugs

Letrozole21 claims

Tamoxifen Citrate19 claims

Exemestane16 claims

Abemaciclib12 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$34

Payment records

By payment type

Food and Beverage$34

REFERRAL NETWORK

Where Charles Osborne's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	142	1,305
Mothaffar Rimawi Hematology-Oncology · Houston, TX	47	271
CHI ST. LUKE'S HEALTH BAYLOR COLLEGE OF MEDICINE MEDICAL CENTER	45	274
SEDGWICK, EMILY	41	88
Julie Nangia Hematology-Oncology · Houston, TX	24	156
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX	20	71
RUDE, MARI	20	45
SABICHI, ANITA	15	94
SADA, YVONNE	12	79
Aihua Yen Hematology-Oncology · Houston, TX	11	40

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history